| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced glycation end-products and peritoneal sclerosis
|
Nakamura, Sakurako
|
|
2004
|
24 |
5 |
p. 502-505
4 p.
|
artikel
|
| 2 |
Arterial calcification in chronic kidney disease
|
Burke, Steven K.
|
|
2004
|
24 |
5 |
p. 403-407
5 p.
|
artikel
|
| 3 |
Calcimimetic agents for the treatment of secondary hyperparathyroidism
|
Goodman, William G.
|
|
2004
|
24 |
5 |
p. 460-463
4 p.
|
artikel
|
| 4 |
Carnitine system in uremic patients: Molecular and clinical aspects
|
Savica, Vincenzo
|
|
2004
|
24 |
5 |
p. 464-468
5 p.
|
artikel
|
| 5 |
Cellular mechanisms causing loss of muscle mass in kidney disease
|
Mitch, William E.
|
|
2004
|
24 |
5 |
p. 484-487
4 p.
|
artikel
|
| 6 |
Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease
|
Sessa, Adalberto
|
|
2004
|
24 |
5 |
p. 532-536
5 p.
|
artikel
|
| 7 |
Chronic systemic inflammation in uremia: Potential therapeutic approaches
|
Guarnieri, Gianfranco
|
|
2004
|
24 |
5 |
p. 441-445
5 p.
|
artikel
|
| 8 |
Continuum of therapy in progressive renal diseases (from predialysis to transplantation): Analysis of a new organizational model
|
Piccoli, Giuseppe
|
|
2004
|
24 |
5 |
p. 506-524
19 p.
|
artikel
|
| 9 |
C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries
|
Ishimura, Eiji
|
|
2004
|
24 |
5 |
p. 408-412
5 p.
|
artikel
|
| 10 |
Disturbances of purine nucleotide metabolism in uremia
|
Rutkowski, Bolesław
|
|
2004
|
24 |
5 |
p. 479-483
5 p.
|
artikel
|
| 11 |
Editorial board
|
|
|
2004
|
24 |
5 |
p. A3-
1 p.
|
artikel
|
| 12 |
Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients
|
Pozzoni, Pietro
|
|
2004
|
24 |
5 |
p. 417-422
6 p.
|
artikel
|
| 13 |
Factors for increased morbidity and mortality in uremia: Hyperphosphatemia
|
Levin, Nathan W.
|
|
2004
|
24 |
5 |
p. 396-400
5 p.
|
artikel
|
| 14 |
Genomic damage in end-stage renal failure: Potential involvement of advanced glycation end products and carbonyl stress
|
Stopper, Helga
|
|
2004
|
24 |
5 |
p. 474-478
5 p.
|
artikel
|
| 15 |
Hyperhomocysteinemia and cardiovascular disease in uremia: The newest evidence in epidemiology and mechanisms of action
|
Perna, Alessandra F.
|
|
2004
|
24 |
5 |
p. 426-430
5 p.
|
artikel
|
| 16 |
Inflammation: Cause of vascular disease and malnutrition in dialysis patients
|
Kaysen, George A.
|
|
2004
|
24 |
5 |
p. 431-436
6 p.
|
artikel
|
| 17 |
Introduction Uremia Research
|
Bellinghieri, Guido
|
|
2004
|
24 |
5 |
p. 395-
1 p.
|
artikel
|
| 18 |
Management of calcium and bone abnormalities in hemodialysis patients
|
Morii, Hirotoshi
|
|
2004
|
24 |
5 |
p. 446-448
3 p.
|
artikel
|
| 19 |
Masthead
|
|
|
2004
|
24 |
5 |
p. A2-
1 p.
|
artikel
|
| 20 |
Mechanisms of vascular calcification in uremia
|
Giachelli, Cecilia M.
|
|
2004
|
24 |
5 |
p. 401-402
2 p.
|
artikel
|
| 21 |
New cellular and molecular approaches for the treatment of cardiac disease
|
Kedes, Laurence
|
|
2004
|
24 |
5 |
p. 437-440
4 p.
|
artikel
|
| 22 |
Oxidative stress in uremia: Nature, mechanisms, and potential consequences
|
Vaziri, Nosratola D.
|
|
2004
|
24 |
5 |
p. 469-473
5 p.
|
artikel
|
| 23 |
Plasma levels of plasminogen activator inhibitor type 1, factor VIII, prothrombin activation fragment 1+2, anticardiolipin, and antiprothrombin antibodies are risk factors for thrombosis in hemodialysis patients
|
Molino, Daniela
|
|
2004
|
24 |
5 |
p. 495-501
7 p.
|
artikel
|
| 24 |
Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: Another form of metabolic syndrome
|
Nishizawa, Yoshiki
|
|
2004
|
24 |
5 |
p. 423-425
3 p.
|
artikel
|
| 25 |
Sagliker syndrome: Uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure
|
Sagliker, Yahya
|
|
2004
|
24 |
5 |
p. 449-455
7 p.
|
artikel
|
| 26 |
Table of contents
|
|
|
2004
|
24 |
5 |
p. A5-A7
nvt p.
|
artikel
|
| 27 |
The role of interleukin-6 and of its soluble receptors in the biocompatibility of dialysis treatment
|
Memoli, Bruno
|
|
2004
|
24 |
5 |
p. 492-494
3 p.
|
artikel
|
| 28 |
Ultrastructural changes of corpora cavernosa in men with erectile dysfunction and chronic renal failure
|
Bellinghieri, Guido
|
|
2004
|
24 |
5 |
p. 488-491
4 p.
|
artikel
|
| 29 |
Uremic vasculopathy
|
Moe, Sharon M.
|
|
2004
|
24 |
5 |
p. 413-416
4 p.
|
artikel
|
| 30 |
Vitamin D analogs: Actions and role in the treatment of secondary hyperparathyroidism
|
Martin, Kevin J.
|
|
2004
|
24 |
5 |
p. 456-459
4 p.
|
artikel
|
| 31 |
Vitamin E-coated dialyzer and antioxidant defense parameters: Three-month study
|
Mydlík, Miroslav
|
|
2004
|
24 |
5 |
p. 525-531
7 p.
|
artikel
|
Tijdschrift beschrijving